← Home
/
Aktis Oncology, Inc. (AKTS)
Stock Analysis
Aktis Oncology, Inc. (AKTS)
AKTS
AKTS · Market data
23.53
+3.98%
Updated: 2026-06-18 13:41 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 23.53. Holding above 19.76 keeps the current thesis intact.
✓
Fundamentals
Insufficient / Negative
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
19.76
↗
Break Above
Confirmation improves above resistance.
23.53
🎯
Next Objective
Pattern-derived target if setup continues.
28.64
×
Thesis Break
Scenario weakens below invalidation.
Below 19.76
What's Driving AKTS?
📈 Technical recovery is improving
Momentum is Neutral. Watch 23.53 for confirmation and 19.76 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 19.76
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
💵 Revenue
3.23M
≈ Insufficient
📈 Net Income
-18.32M
↘ Negative
🧮 EPS (Basic)
-0.38
↘ Negative
Note: This is an algorithmic technical snapshot, not financial advice.